{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:18:51Z","timestamp":1775596731691,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jiac.2019.08.002","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T09:25:42Z","timestamp":1567243542000},"page":"170-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Yaeko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.08.002_bib1","doi-asserted-by":"crossref","first-page":"J99","DOI":"10.3314\/mmj.56.J99","article-title":"Epidemiology of visceral mycoses in autopsy cases in 2011","volume":"56J","author":"Suzuki","year":"2015","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jiac.2019.08.002_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","article-title":"Itraconazole oral solution and intravenous formulation: a review of pharmacokinetics and pharmacodynamics","volume":"26","author":"Willems","year":"2001","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jiac.2019.08.002_bib3","first-page":"657","article-title":"Clinical practice guidelines for the treatment of pulmonary aspergillosis in non-hematologic disorders","volume":"62","author":"Ando","year":"2014","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2019.08.002_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2019.08.002_bib5","first-page":"290","article-title":"In\u00a0vitro antifungal activities of hydroxy-itraconazole, an active metabolite of itraconazole","volume":"42","author":"Mikami","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jiac.2019.08.002_bib6","first-page":"347","article-title":"The guideline of antifungal clinical evaluation by the committee of antifungal clinical evaluation, Japanese society of chemotherapy","volume":"60","year":"2012","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2019.08.002_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bmt.1704614","article-title":"A\u00a0pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mold infections following allogeneic stem cell transplantation","volume":"34","author":"Grigg","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2019.08.002_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2019.08.002_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/10428199809050939","article-title":"Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients","volume":"30","author":"Lamy","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jiac.2019.08.002_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","article-title":"Azole resistance in aspergillus: a growing public health menace","volume":"6","author":"Denning","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jiac.2019.08.002_bib11","first-page":"105","article-title":"The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal","volume":"27","author":"Stein","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2019.08.002_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050438","article-title":"Effect of omeprazole on the pharmacokinetics of itraconazole","volume":"54","author":"Jaruratanasirikul","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2019.08.002_bib13","first-page":"87","article-title":"Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects","volume":"14","author":"Zimmermann","year":"1994","journal-title":"Int J Clin Pharm"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:09Z","timestamp":1761159609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19302363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1341321X19302363"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}